» Articles » PMID: 34834205

Nanoencapsulation As a General Solution for Lyophilization of Labile Substrates

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2021 Nov 27
PMID 34834205
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Protein macromolecules occur naturally at the nanoscale. The use of a dedicated nanoparticle as a lyophilization excipient, however, has not been reported. Because biopolymeric and lipid nanoparticles often denature protein macromolecules and commonly lack the structural rigidity to survive the freeze-drying process, we hypothesized that surrounding an individual protein substrate with a nanoscale, thermostable exoshell (tES) would prevent aggregation and protect the substrate from denaturation during freezing, sublimation, and storage. We systematically investigated the properties of tES, including secondary structure and its homogeneity, throughout the process of lyophilization and found that tES have a near 100% recovery following aqueous reconstitution. We then tested the hypothesis that tES could encapsulate a model substrate, horseradish peroxidase (HRP), using charge complementation and pH-mediated controlled assembly. HRP were encapsulated within the 8 nm internal tES aqueous cavity using a simplified loading procedure. Time-course experiments demonstrated that unprotected HRP loses 95% of activity after 1 month of lyophilized storage. After encapsulation within tES nanoparticles, 70% of HRP activity was recovered, representing a 14-fold improvement and this effect was reproducible across a range of storage temperatures. To our knowledge, these results represent the first reported use of nanoparticle encapsulation to stabilize a functional macromolecule during lyophilization. Thermostable nanoencapsulation may be a useful method for the long-term storage of labile proteins.

Citing Articles

New Trends in Freeze-Drying of Pharmaceutical Products.

Pisano R, Fissore D Pharmaceutics. 2023; 15(7).

PMID: 37514161 PMC: 10383798. DOI: 10.3390/pharmaceutics15071975.


T Cell Activating Thermostable Self-Assembly Nanoscaffold Tailored for Cellular Immunity Antigen Delivery.

Zhang J, Yang J, Li Q, Peng R, Fan S, Yi H Adv Sci (Weinh). 2023; 10(26):e2303049.

PMID: 37395451 PMC: 10502629. DOI: 10.1002/advs.202303049.


Gastrointestinal Tract Stabilized Protein Delivery Using Disulfide Thermostable Exoshell System.

Sadeghi S, Vallerinteavide Mavelli G, Vaidya S, Drum C Int J Mol Sci. 2022; 23(17).

PMID: 36077259 PMC: 9456531. DOI: 10.3390/ijms23179856.

References
1.
Al-Bagmi M, Khan M, Alhasan Ismael M, Al-Senaidy A, Ben Bacha A, Husain F . An efficient methodology for the purification of date palm peroxidase: Stability comparison with horseradish peroxidase (HRP). Saudi J Biol Sci. 2019; 26(2):301-307. PMC: 6717102. DOI: 10.1016/j.sjbs.2018.04.002. View

2.
Lu R, Hwang Y, Liu I, Lee C, Tsai H, Li H . Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020; 27(1):1. PMC: 6939334. DOI: 10.1186/s12929-019-0592-z. View

3.
Bonifert G, Folkes L, Gmeiner C, Dachs G, Spadiut O . Recombinant horseradish peroxidase variants for targeted cancer treatment. Cancer Med. 2016; 5(6):1194-203. PMC: 4924378. DOI: 10.1002/cam4.668. View

4.
Chaturvedi S, Parupudi A, Juul-Madsen K, Nguyen A, Vorup-Jensen T, Dragulin-Otto S . Measuring aggregates, self-association, and weak interactions in concentrated therapeutic antibody solutions. MAbs. 2020; 12(1):1810488. PMC: 7531506. DOI: 10.1080/19420862.2020.1810488. View

5.
Fu B, Curry F, Adamson R, Weinbaum S . A model for interpreting the tracer labeling of interendothelial clefts. Ann Biomed Eng. 1997; 25(2):375-97. DOI: 10.1007/BF02648050. View